secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001193125-24-205378
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellevue Life Sciences receives second Nasdaq delisting notice for insufficient public holders
--------------------------------------------------------------------------------

- Nasdaq notified company on Aug 20, 2024 that it failed to regain compliance with minimum 300 public holders requirement by Aug 13, 2024 deadline.
- Company previously received initial notice on Feb 15, 2024 and submitted a compliance plan; extension granted until Aug 13, 2024.
- Company intends to timely request a hearing before Nasdaq Hearings Panel, which will automatically stay suspension or delisting.
- Securities affected: units (BLACU), common stock (BLAC), warrants (BLACW), rights (BLACR).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524205378/0001193125-24-205378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524205378/d227622d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-205378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer